173 related articles for article (PubMed ID: 14638545)
1. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction.
Sadeghi HM; Stone GW; Grines CL; Mehran R; Dixon SR; Lansky AJ; Fahy M; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD
Circulation; 2003 Dec; 108(22):2769-75. PubMed ID: 14638545
[TBL] [Abstract][Full Text] [Related]
2. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
Nikolsky E; Aymong ED; Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Cohen DA; Negoita M; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 Aug; 44(3):547-53. PubMed ID: 15358018
[TBL] [Abstract][Full Text] [Related]
3. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Pellizzon GG; Grines CL; Cox DA; Stuckey T; Tcheng JE; Garcia E; Guagliumi G; Turco M; Lansky AJ; Griffin JJ; Cohen DJ; Aymong E; Mehran R; O'Neill WW; Stone GW
J Am Coll Cardiol; 2004 Apr; 43(8):1368-74. PubMed ID: 15093869
[TBL] [Abstract][Full Text] [Related]
4. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial).
Nikolsky E; Grines CL; Cox DA; Garcia E; Tcheng JE; Sadeghi M; Mehran R; Lansky AJ; Na Y; Stone GW
Am J Cardiol; 2007 Apr; 99(8):1055-61. PubMed ID: 17437727
[TBL] [Abstract][Full Text] [Related]
5. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
[TBL] [Abstract][Full Text] [Related]
7. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
[TBL] [Abstract][Full Text] [Related]
8. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
Nikolsky E; Sadeghi HM; Effron MB; Mehran R; Lansky AJ; Na Y; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD; Grines CL; Stone GW
Am J Cardiol; 2005 Aug; 96(4):474-81. PubMed ID: 16098296
[TBL] [Abstract][Full Text] [Related]
9. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.
Zhang RY; Zhu ZB; Zhang Q; Yang ZK; Hu J; Lv AK; Zhang JS; Shen WF
Int J Cardiol; 2009 Jul; 136(1):72-9. PubMed ID: 18653250
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Lansky AJ; Pietras C; Costa RA; Tsuchiya Y; Brodie BR; Cox DA; Aymong ED; Stuckey TD; Garcia E; Tcheng JE; Mehran R; Negoita M; Fahy M; Cristea E; Turco M; Leon MB; Grines CL; Stone GW
Circulation; 2005 Apr; 111(13):1611-8. PubMed ID: 15811868
[TBL] [Abstract][Full Text] [Related]
11. Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials).
Garg P; Charytan DM; Novack L; Cutlip DE; Popma JJ; Moses J; Leon MB; Schofer J; Breithardt G; Schampaert E; Mauri L
Am J Cardiol; 2010 Nov; 106(10):1436-42. PubMed ID: 21059433
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
Nikolsky E; Mehran R; Sadeghi HM; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2009 Jul; 2(7):624-32. PubMed ID: 19628185
[TBL] [Abstract][Full Text] [Related]
13. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
14. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.
Prasad A; Stone GW; Aymong E; Zimetbaum PJ; McLaughlin M; Mehran R; Garcia E; Tcheng JE; Cox DA; Grines CL; Gersh BJ;
Am Heart J; 2004 Apr; 147(4):669-75. PubMed ID: 15077083
[TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
[TBL] [Abstract][Full Text] [Related]
16. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
Brodie BR; Gersh BJ; Stuckey T; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Grines CL; Cox D; Parise H; Prasad A; Lansky AJ; Mehran R; Stone GW
J Am Coll Cardiol; 2010 Jul; 56(5):407-13. PubMed ID: 20650362
[TBL] [Abstract][Full Text] [Related]
17. Glycoprotein IIb/IIIa receptor inhibition with abciximab during percutaneous coronary interventions increases the risk of bleeding in patients with impaired renal function.
Pinkau T; Ndrepepa G; Kastrati A; Mann JF; Schulz S; Mehilli J; Schömig A
Cardiology; 2008; 111(4):247-53. PubMed ID: 18434733
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
Mehilli J; Kastrati A; Schühlen H; Dibra A; Dotzer F; von Beckerath N; Bollwein H; Pache J; Dirschinger J; Berger PP; Schömig A;
Circulation; 2004 Dec; 110(24):3627-35. PubMed ID: 15531766
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
[TBL] [Abstract][Full Text] [Related]
20. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
